{"id":"W2591276563","doi":"10.1002/acr.23233","title":"Secukinumab and Sustained Improvement in Signs and Symptoms of Patients With Active Ankylosing Spondylitis Through Two Years: Results From a Phase III Study","year":2017,"lang":"en","type":"article","venue":"Arthritis Care & Research","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"Genentech; Celgene; Sanofi; Pfizer","keywords":"Secukinumab; Medicine; Ankylosing spondylitis; Placebo; Adverse effect; Clinical endpoint; Internal medicine; Randomized controlled trial; Gastroenterology; Rheumatoid arthritis; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002152466,0.0008061351,0.001643688,0.0002143383,0.0003318704,0.0006792937,0.0005148636,0.0008450365,0.001918269],"category_scores_gemma":[0.0009282898,0.0002993371,0.001214956,0.0003017696,0.0004852518,0.0004543246,0.0002092557,0.001567088,0.0004847763],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003962746,"about_ca_system_score_gemma":0.000586247,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003585453,"about_ca_topic_score_gemma":0.000818093,"domain_scores_codex":[0.9994475,0.0002874196,0.00004730438,0.00005751693,0.00007528083,0.00008495704],"domain_scores_gemma":[0.9991554,0.000173133,0.0002652346,0.0000789843,0.00007690208,0.0002503415],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6239673,0.06399392,0.02600047,0.002042232,0.005143478,0.0004326724,0.000529153,0.001720628,0.04755482,0.0001637882,0.004082969,0.2243686],"study_design_scores_gemma":[0.4376467,0.4717342,0.08133418,0.00009539874,0.001261687,0.0004667674,0.00009453401,0.0009291272,0.004032922,0.00008564334,0.002280001,0.00003894162],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948317,0.003350692,0.0002519821,0.0002121747,0.00006742661,0.0004545367,0.000313398,0.00004902491,0.0004690442],"genre_scores_gemma":[0.9955567,0.001487414,0.0005108814,0.0004827522,0.0001044391,0.0005352767,0.000633482,0.0000121293,0.0006770623],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002152466,"threshold_uncertainty_score":0.01138347,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02682826086176169,"score_gpt":0.365604717089153,"score_spread":0.3387764562273913,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}